506906 — Saptak Chem and Business Balance Sheet
0.000.00%
Last trade - 00:00- IN₹86.67m
- IN₹110.68m
Annual balance sheet for Saptak Chem and Business, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 1.41 | 0.255 | 0.082 | 2.53 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 8.85 | — | — | — |
| Total Other Current Assets | ||||
| Total Current Assets | 10.3 | 1.61 | 1.35 | 11.5 |
| Long Term Notes Receivable | ||||
| Total Assets | 15.6 | 1.61 | 1.35 | 11.5 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 37 | 23.3 | 23.9 | 26.6 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 37 | 23.3 | 23.9 | 26.6 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -21.4 | -21.7 | -22.6 | -15.1 |
| Total Liabilities & Shareholders' Equity | 15.6 | 1.61 | 1.35 | 11.5 |
| Total Common Shares Outstanding |